ArticleOpen Access http://dx.doi.org/10.26855/ijcemr.2017.01.001
Clinical Value of TCT Used in Gynaecological Diseases to Make a General Survey of Cervical Precancerous Lesions
Fedor Kufova
Na Homolce Hospital, Ostrava-Poruba, Czech Republic.
*Corresponding author: Fedor Kufova
19
Published: December 09, 2017
Abstract
Objective: It analyzes and discusses about the clinical value of Thinprep cytology test (TCT) used in gynaecological diseases to make a general survey of cervical precancerous lesions, which offers scientific basis to the formulation of intervention measures. Method: It carries out retrospective analysis on the 5,207 cases of the gynaecological diseases under the general survey from January 1, 2011 to December 31, 2013 in our hospital. Among them, there are 1,602 cases from profession teachers, 3,308 cases from staffs of common public institutions, and 297 cases from people with other occupations. Result: Upon the physical examination, it is found that the morbidity in myoma of uterus and cyclomastopathy among professional teachers is higher than that among the common women in public institutions obviously (χ2=12.77, p =0.014). Conclusion: There is a relatively long stage of precancerous lesions in the generation of cervical cancer, so cervix uteri cytology test is an effective way for screening precancerous cell lesions. TCT can increase diagnosis accuracy, discover early lesions of cervix uteri in time, and reduce the incidence rate of cervical cancer.
Keyword
TCT; cervical precancerous lesions; clinical value
References
[1] Gauravi, A.M., Sharmila, A.P., and Surendra, S.S. (2011) An overview of prevention and early detection of cervical cancers. Indian J Med Paediatr Oncol, 32(3): 125-132.
[2] Kawana, K., Yasugi, T., Taketani, Y. (2009) Human papillomavirus vaccines: Current issues and future. Indian J Med Res, 130:341-7.
[3] Susini, T., Olivieri, S., Molino, C., et al. (2011) DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study. Int J Gynecol Cancer, 21(4):678-684.
[4] Berrington, D.G., Sweetland, S., Green, J. (2004) Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: A meta-analysis. Br J Cancer, 90(9):1787-91.
[5] Trottier, H., Franco, E.L. (2006)The epidemiology of genital human papillomavirus infection. Vaccine, 24(supplement 1):S1-15.
Copyright
© 2017 by the author(s).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not modified or adapted.
https://creativecommons.org/licenses/by-nc-nd/4.0/
How to cite this paper
Clinical Value of TCT Used in Gynaecological Diseases to Make a General Survey of Cervical Precancerous Lesions
How to cite this paper: Fedor Kufova. (2017). Clinical Value of TCT Used in Gynaecological Diseases to Make a General Survey of Cervical Precancerous Lesions. International Journal of Clinical and Experimental Medicine Research, 1(1), 1-4.
DOI: http://dx.doi.org/10.26855/ijcemr.2017.01.001